Aaron Snyder, MSc, C Gmp
About Aaron Snyder, MSc, C Gmp
Aaron Snyder, MSc, C Gmp, serves as the Head of Quality Assurance at Fresenius Kabi in Norway. With extensive experience in quality assurance and regulatory compliance across various companies, he has held significant roles at Mölnlycke, Covidien, and Waters, among others.
Work at Fresenius Kabi
Aaron Snyder has been serving as the Head of Quality Assurance at Fresenius Kabi since 2021. In this role, he oversees quality assurance processes and ensures compliance with regulatory standards. His leadership in quality assurance is critical to maintaining the integrity of the company's products and services in Norway.
Previous Experience at Mölnlycke
Before joining Fresenius Kabi, Aaron Snyder worked at Mölnlycke as the Director of Global Quality Assurance from 2018 to 2021. During his tenure in Gothenburg, Sweden, he focused on strategic planning and quality assurance initiatives, contributing to the company's commitment to high-quality healthcare solutions.
Education and Expertise
Aaron Snyder holds a Bachelor’s degree in Industrial Management from Purdue University and a Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University. His educational background equips him with the knowledge necessary for his roles in quality assurance and regulatory compliance.
Career Background
Aaron Snyder has extensive experience in quality assurance and regulatory compliance across various organizations. He has held positions at Covidien, Waters, Cardinal Health, and General Electric. His roles have included responsibilities such as project management, FDA audit management, and quality management system expertise.
Achievements in Quality Assurance
Throughout his career, Aaron Snyder has demonstrated expertise in quality assurance and regulatory compliance. He has been involved in training FDA and industry personnel as a Lead Faculty at AAMI since 2015, focusing on standards such as 21 CFR 820 and ISO 13485:2016. His contributions have significantly impacted quality assurance practices in the medical device industry.